Sex Differences in the Genetic Causes of Dilated Cardiomyopathy.
作者信息
Mangino Massimo, McGurk Kathryn A, Theotokis Pantazis, Buchan Rachel J, Stockwell Clare R, Thami Prisca K, Jennings Emma, Wan Elaine, Enright Catherine, Adlan Ahmed, Akbari Tamim, Baksi John, Barton Paul J R, Berry Colin, Carr-White Gerry, Chiribiri Amedeo, Cooper Rob, Dattani Abhishek, Flett Andrew S, Gardner Roy S, Greenwood John P, Halliday Brian P, Hammersley Daniel J, Hutchings David C, Mahmod Masliza, Marrow Benjamin, McCann Gerry P, Motwani Manish, Neubauer Stefan, O' Regan Declan P, Page Stephen P, Pantazis Antonis, Peebles Charles, Raman Betty, Swoboda Peter P, Varnava Amanda, Venetucci Luigi, Watkins Hugh, Wright David, Prasad Sanjay K, Cook Stuart A, Ware James S, Tayal Upasana Paz
机构信息
National Heart and Lung Institute, Imperial College London, London, United Kingdom; King's College London, London, United Kingdom.
National Heart and Lung Institute, Imperial College London, London, United Kingdom; MRC Laboratory of Medical Sciences, Imperial College London, London, United Kingdom.
出版信息
J Am Coll Cardiol. 2025 Aug 5;86(5):400-403. doi: 10.1016/j.jacc.2025.04.068.
Abstract
摘要
相似文献
1
Sex Differences in the Genetic Causes of Dilated Cardiomyopathy.扩张型心肌病遗传病因中的性别差异
J Am Coll Cardiol. 2025 Aug 5;86(5):400-403. doi: 10.1016/j.jacc.2025.04.068.
2
National Trends in Admissions, Treatments, and Outcomes for Dilated Cardiomyopathy (2016-2021).扩张型心肌病的入院、治疗及预后的全国趋势（2016 - 2021年）
Med Sci (Basel). 2025 Jun 23;13(3):83. doi: 10.3390/medsci13030083.
3
A Proposed Genetic Risk Score for Dilated Cardiomyopathy Susceptibility in the Chinese Han Population.中国汉族人群扩张型心肌病易感性的遗传风险评分方案。
Tex Heart Inst J. 2025 May 16;52(1):e248525. doi: 10.14503/THIJ-24-8525. eCollection 2025 Jan-Jun.
4
TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study.扩张型心肌病患者的 TTR 变异体：DCM 精准医学研究的调查。
Genet Med. 2022 Jul;24(7):1495-1502. doi: 10.1016/j.gim.2022.03.011. Epub 2022 Apr 18.
5
Sex Differences in the Clinical Presentation and Natural History of Dilated Cardiomyopathy.扩张型心肌病的临床表现和自然史的性别差异。
JACC Heart Fail. 2024 Feb;12(2):352-363. doi: 10.1016/j.jchf.2023.10.009. Epub 2023 Nov 29.
6
Critical predictors of heart transplant necessity in children with advanced DCM.晚期扩张型心肌病患儿心脏移植必要性的关键预测因素。
Ital J Pediatr. 2025 Aug 20;51(1):256. doi: 10.1186/s13052-025-02111-7.
7
Polymorphisms of CD247 gene is associated with dilated cardiomyopathy in Chinese Han population.CD247 基因多态性与中国汉族人群扩张型心肌病的相关性。
BMC Cardiovasc Disord. 2024 Sep 12;24(1):487. doi: 10.1186/s12872-024-04160-y.
8
Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: A systematic review and meta-analysis.扩张型心肌病患者自身抗体的频率及其相关临床特征和预后：一项系统评价和荟萃分析。
Autoimmun Rev. 2025 Mar 26;24(4):103755. doi: 10.1016/j.autrev.2025.103755. Epub 2025 Jan 22.
9
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy.心律失常表型在扩张型心肌病的预后分层和管理中的作用。
Eur J Heart Fail. 2024 Mar;26(3):581-589. doi: 10.1002/ejhf.3168. Epub 2024 Feb 26.
10
Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3.BAG3中扩张型和肥厚型心肌病的双向风险调节因子及修饰变异体
JAMA Cardiol. 2024 Dec 1;9(12):1124-1133. doi: 10.1001/jamacardio.2024.3547.
本文引用的文献
1
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.一种用于桥粒芯蛋白基因突变携带者心律失常风险分层的新工具。
Eur Heart J. 2024 Aug 21;45(32):2968-2979. doi: 10.1093/eurheartj/ehae409.
2
A genomic mutational constraint map using variation in 76,156 human genomes.基于 76156 个人类基因组的变异，绘制出基因组突变约束图谱。
Nature. 2024 Jan;625(7993):92-100. doi: 10.1038/s41586-023-06045-0. Epub 2023 Dec 6.
3
Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions.超越基因-疾病有效性：获取关于遗传性、等位基因需求、与疾病相关的变异类别和遗传性心脏疾病发病机制的结构化数据。
Genome Med. 2023 Oct 23;15(1):86. doi: 10.1186/s13073-023-01246-8.
4
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.心肌病相关基因中罕见变异的外显率：一种用于估计次要发现外显率的横断面方法。
Am J Hum Genet. 2023 Sep 7;110(9):1482-1495. doi: 10.1016/j.ajhg.2023.08.003. Epub 2023 Aug 30.
5
Reproductive History Assessments in Cardiovascular Care: We Need to Start by Asking.心血管护理中的生殖史评估：我们需要从询问开始。
JACC Heart Fail. 2023 Sep;11(9):1213-1215. doi: 10.1016/j.jchf.2023.03.018. Epub 2023 May 3.
6
Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know.了解成人扩张型心肌病的遗传学：临床医生需要知道什么。
Eur Heart J. 2021 Jun 21;42(24):2384-2396. doi: 10.1093/eurheartj/ehab286.
7
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.基于证据的扩张型心肌病相关基因评估。
Circulation. 2021 Jul 6;144(1):7-19. doi: 10.1161/CIRCULATIONAHA.120.053033. Epub 2021 May 5.
8
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy.重新评估单基因扩张型心肌病的遗传贡献。
Circulation. 2020 Feb 4;141(5):387-398. doi: 10.1161/CIRCULATIONAHA.119.037661. Epub 2020 Jan 27.
9
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.扩张型心肌病、运动减弱非扩张型心肌病修订定义的建议及其对临床实践的影响：ESC 心肌和心包疾病工作组立场声明。
Eur Heart J. 2016 Jun 14;37(23):1850-8. doi: 10.1093/eurheartj/ehv727. Epub 2016 Jan 19.
10
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.基因组分析工具包：一种用于分析下一代 DNA 测序数据的 MapReduce 框架。
Genome Res. 2010 Sep;20(9):1297-303. doi: 10.1101/gr.107524.110. Epub 2010 Jul 19.
Zotero 插件